InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,064.20
(
0.91%
)
US TECH 100
17,173.20
(
1.85%
)
Dow Jones
38,225.66
(
0.85%
)
Brent Oil
83.92
(
0.34%
)
Bitcoin
59,332.34
(
0.36%
)

Replies to post #7817 on Provectus Biopharmaceuticals Inc (PVCT)

Replies to #7817 on Provectus Biopharmaceuticals Inc (PVCT)

Bob Dolina

07/06/15 9:17 PM

#7818 RE: Paulness #7817

Looks very promising that this will move to phase 2 studies. The adverse events are mild compared most phase 1 studies.